234 related articles for article (PubMed ID: 35978883)
1. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.
Akiyama S; Fukuda S; Steinberg JM; Suzuki H; Tsuchiya K
World J Gastroenterol; 2022 Jul; 28(25):2843-2853. PubMed ID: 35978883
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
Attauabi M; Zhao M; Bendtsen F; Burisch J
Inflamm Bowel Dis; 2021 May; 27(6):927-939. PubMed ID: 32628745
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
Attauabi M; Wewer MD; Bendtsen F; Seidelin JB; Burisch J
Inflamm Bowel Dis; 2022 Nov; 28(11):1756-1765. PubMed ID: 35134921
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study.
Vernero M; Saibeni S; Scalvini D; Cicalini C; Chiarello L; Nardi S; Ribaldone DG; Bezzio C
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398332
[No Abstract] [Full Text] [Related]
8. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
[TBL] [Abstract][Full Text] [Related]
9. Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach.
García MJ; Pascual M; Del Pozo C; Díaz-González A; Castro B; Rasines L; Crespo J; Rivero M
Sci Rep; 2020 Jul; 10(1):10731. PubMed ID: 32612137
[TBL] [Abstract][Full Text] [Related]
10. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.
Henriksen EK; Jørgensen KK; Kaveh F; Holm K; Hamm D; Olweus J; Melum E; Chung BK; Eide TJ; Lundin KE; Boberg KM; Karlsen TH; Hirschfield GM; Liaskou E
J Hepatol; 2017 Jan; 66(1):116-122. PubMed ID: 27647428
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
[TBL] [Abstract][Full Text] [Related]
13. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
[TBL] [Abstract][Full Text] [Related]
14. The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.
Schaeffer DF; Win LL; Hafezi-Bakhtiari S; Cino M; Hirschfield GM; El-Zimaity H
Dig Dis Sci; 2013 Sep; 58(9):2608-14. PubMed ID: 23670229
[TBL] [Abstract][Full Text] [Related]
15. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
Broomé U; Löfberg R; Lundqvist K; Veress B
Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
[TBL] [Abstract][Full Text] [Related]
16. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
Christensen B; Micic D; Gibson PR; Yarur A; Bellaguarda E; Corsello P; Gaetano JN; Kinnucan J; Rao VL; Reddy S; Singh S; Pekow J; Rubin DT
Aliment Pharmacol Ther; 2018 Mar; 47(6):753-762. PubMed ID: 29377235
[TBL] [Abstract][Full Text] [Related]
17. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
18. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis.
Bajer L; Wohl P; Drastich P
Vnitr Lek; 2018; 64(6):659-664. PubMed ID: 30223664
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.
Shearn CT; Orlicky DJ; Petersen DR
Exp Mol Pathol; 2018 Feb; 104(1):1-8. PubMed ID: 29180269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
